In AD model mice, B1R antagonist SSR240612 not only reduced microglial activation, diffuse and dense-core Aβ plaques, brain levels of soluble Aβ1–42, but also remarkably improved spatial learning and memory. This evidence concerns the gene BDKRB1 and Alzheimer disease.